This opportunity is now closed.

Funded PhD Opportunity

Extraction, characterization and exploitation of marine derived bioactive peptides for enhancing health

Subject: Biomedical Sciences


Summary

Background:

Low-value pelagic fish (e.g. Blue whiting) provide an abundant source of underutilized and potentially high-value functional proteins and peptides [1]. This project will investigate the potential of biofunctional peptides derived from the enzymatic digestion of marine proteins, to enhance satiety and reduce food intake. Fish protein hydrolysates (FPH) will be screened using cellular bioassays associated with markers of appetite control. Lead candidates that reduce food intake will be assessed in acute and chronic mouse studies. Lead hydrolysates will be formulated into food products and sensory studies performed. LC-MS analysis will help characterise the peptide profile and identify the bioactive peptides present in hydrolysates. This project will help validate the strategic use of fish protein hydrolysates for health promotion and disease prevention.

Objective:

The main objective will be to characterise biofunctional peptide ingredients from fish protein hydrolysates with appetite modulating activities.

Study 1: Fish protein hydrolysates (FPH), will be tested in pancreatic BRIN-BD11 cells [2], measuring insulin secretion by RIA, and cytotoxicity by MTT and LDH assays. Bioactive peptides from FPH affecting appetite control hormones will be screened and identified using RP-HPLC and LC-MS.  Identified synthetic peptides will be tested on cellular appetite hormone secretion and food intake in mice.

Study 2: Adult male NIH Swiss mice (4 groups of n=8) will be conditioned to eat for 3 h per day (10.00 h to 13.00 h).  Food intake will be assessed at 30 min intervals up to 180 min, following oral gavage with selected FPH or synthetic peptides (oral/i.p. injection) [3].

Study 3: Following oral glucose challenge with or without hydrolysate (50 and 200 mg/kg) blood glucose, plasma PYY, ghrelin, total GLP-1, CCK-8, glucagon and insulin concentrations, and DPP-4 enzyme activity will be assessed from tail blood at regular intervals (0-120 min). A delayed oral glucose tolerance test (OGTT) will be undertaken (2, 4, 8 and 12 h) to obtain information on the pharmacokinetics and duration of action of hydrolysates [4] to determine the frequency of dosing for Task 4.

Study 4: Chronic effects of FPH will be tested for 28 days in a high-fat fed mouse model of diet-induced obesity (DIO) [5].  Food intake, non-fasting blood glucose, plasma insulin, plasma GLP-1, PYY, CCK-8, ghrelin, DPP-4 activity and body weight will be determined at regular intervals up to 28 days.  An OGTT and insulin sensitivity test will be performed after 28 days. The CLAMS apparatus will determine energy intake and expenditure [6]. The PIXImus DEXA scanner will measure body composition and bone density [7].

These studies will inform development of appetite modulating hydrolysates and their incorporation into food products, including ongoing sensory analysis with collaborators in Galway and Limerick.

References:

[1] Harnedy et al., Journal of Functional Foods 2018;40:137-145

[2] McClenaghan NH, et al., Diabetes, 1996;45:1132-1140.

[3] O'Harte FPM, et al., Diabetes, 1998;47:1619-1624.

[4] Lynch AM, et al., European Journal of Pharmacology, 2014;743:69-78.

[5] O'Harte FPM, et al., Molecular and Cellular Endocrinology, 2013;381:26-34.

[6] Gault VA, et al., Journal of Endocrinology, 2011;208:265-271.

[7] Pathak V, et al., Molecular and Cellular Endocrinology, 2015;401:120-129.


Essential criteria

  • To hold, or expect to achieve by 15 August, an Upper Second Class Honours (2:1) Degree or equivalent from a UK institution (or overseas award deemed to be equivalent via UK NARIC) in a related or cognate field.

Desirable Criteria

If the University receives a large number of applicants for the project, the following desirable criteria may be applied to shortlist applicants for interview.

  • Experience using research methods or other approaches relevant to the subject domain
  • Experience of presentation of research findings

Funding

    The University offers the following awards to support PhD study and applications are invited from UK, EU and overseas for the following levels of support:

    Department for the Economy (DFE)

    The scholarship will cover tuition fees at the Home rate and a maintenance allowance of £ 15,009 per annum for three years. EU applicants will only be eligible for the fee’s component of the studentship (no maintenance award is provided). For Non-EU nationals the candidate must be "settled" in the UK. This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.

    Due consideration should be given to financing your studies; for further information on cost of living etc. please refer to: www.ulster.ac.uk/doctoralcollege/postgraduate-research/fees-and-funding/financing-your-studies

DfE matched funding


Other information


The Doctoral College at Ulster University


Reviews

Profile picture of Kieran O'Donnell

My experience has been great and the people that I have worked with have been amazing

Kieran O'Donnell - 3D printing of biological cells for tissue engineering applications

Watch Video  

Profile picture of Michelle Clements Clements

Completing the MRes provided me with a lot of different skills, particularly in research methods and lab skills.

Michelle Clements Clements - MRes - Life and Health Sciences

Watch Video  

Profile picture of William Crowe

Throughout my PhD I’ve been provided with continuous support and guidance by my supervisors and the staff at the University.I’ve also received many opportunities to further enhance my professional development in the form of teaching experience and presenting my work at conferences which will aid in my pursuit of a career in academia or industry.

William Crowe


Key dates

Submission deadline
Friday 29 June 2018

Interview Date
To be confirmed


Applying

Apply Online  


Contact supervisor

Professor Finbarr O'Harte


Other supervisors

Related Funded Opportunities

Role of B-vitamins in Epigenetic Modulation of Hypertension

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Engineering plasmid nanoparticles as a platform for delivery of therapeutics

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Diabetes

Subject: Biomedical Sciences

 View details

Graphene family materials as novel chronic wound therapeutics

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

Investigation of microRNA regulation and function in prostate cancer

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Role of novel cardiac biomarkers in cellular senescence

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Oxygen-generating biomaterials for use in wound dressing strategies

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

Development and evaluation of a web-based interactive teaching tool for Optometrists

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

The production of rhamnolipid biosurfactant by Pseudomonas aeruginosa growing in biofilms.

Closing date:
Tuesday 1 September 2020
Subject: Biomedical Sciences

 View details

The regulation of rhamnolipid biosynthesis in Burkholderia thailandensis.

Closing date:
Tuesday 1 September 2020
Subject: Biomedical Sciences

 View details

Naturally-occurring microbial biosynthetic pathways for propane

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Genomic Medicine

Subject: Biomedical Sciences

 View details

Novel fatty acid receptors in islet cells as therapeutic targets for diabetes

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Interactome visualisation of ALS using virtual reality

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Stratified Medicine

Subject: Biomedical Sciences

 View details

Novel amphibian skin peptide-analogues for the treatment of type-2 diabetes

Closing date:
Friday 18 September 2020
Subject: Biomedical Sciences

 View details

Blue whiting protein hydrolysates for management of sarcopenia

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Targeted exendin/apelin hybrid peptides for diabetes and obesity therapy.

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Optometry and Vision Science

Subject: Biomedical Sciences

 View details

MRes in Biomedical Sciences

Subject: Biomedical Sciences

 View details

Regulation of glucose metabolism by incretin signalling

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Mental Health Diagnosis using Cognitive Analytics

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Psychology, Psychiatry and Neuroscience

 View details

Identifying biomarkers that may affect diabetes comorbidity

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

The Growing Problem of Myopia: are spectacles part of the problem?

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Improving the screening and diagnosis of familial hypercholesterolemia

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

Computational approaches to investigate multimorbidity in depression

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

The role of dietary fatty acids and the gut microbiota on autoimmunity

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

A novel therapeutic targeting the inflammasome as a treatment for glaucoma.

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Nutrition and the gut microbiome: impact on brain health in older adults

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Investigation of oral and blood microbiome shifts in patients with depression.

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Vitamin D across the lifecycle to inform nutritional policies

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Epigenomic Profiling of Young Adults with Mental Health Disorders in Northern Ireland

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Investigation of the modifying effects of selenium in the relationship between methylmercury and child development

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Biomedical Sciences

 View details

Towards seeing clearly: does the shape of the eye’s optics affect our focus?

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Changing dietary patterns in the Seychelles and implications for public health

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details